CD274 and neoplasm: Several studies reported on PD-L1 expression; the proportion of patients with a PD-L1 tumor proportion score (TPS) ≥1% ranged from 20.6% to 100%, TPS 1-49% ranged from 0% to 67.3%, and TPS ≥50% ranged from 11.8% to 100%.